June 2013: Capital increase successful

0 Flares 0 Flares ×

In June 2013, InnoMedica was able to complete the Capital Increase approved at the Annual General successfully. The newly acquired capital in the amount of more than CHF 500,000 allows InnoMedica to pursue the establishment of the glucose-based drug-targeting system in oncology determinedly . The capital will be used primarily in the production of a first batch for preclinical toxicity studies.

0 Flares Twitter 0 Facebook 0 Google+ 0 LinkedIn 0 0 Flares ×